Cacti Asset Management’s Precigen PGEN Stock Holding History

Cacti Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,500	Closed	-$11.9K	–	78
2025 Q1	$11.9K	Hold	7,500	–	–	﹤0.01%	76
2024 Q4	$6.97K	Hold	7,500	–	–	﹤0.01%	74
2024 Q3	$7.28K	Hold	7,500	–	–	﹤0.01%	76
2024 Q2	$11.3K	Hold	7,500	–	–	﹤0.01%	78
2024 Q1	$10.2K	Hold	7,500	–	–	﹤0.01%	79
2023 Q4	$10.5K	Hold	7,500	–	–	﹤0.01%	78
2023 Q3	$10.7K	Hold	7,500	–	–	﹤0.01%	79
2023 Q2	$8.63K	Hold	7,500	–	–	﹤0.01%	79
2023 Q1	$7.95K	Hold	7,500	–	–	﹤0.01%	80
2022 Q4	$11.4K	Hold	7,500	–	–	﹤0.01%	78
2022 Q3	$16K	Hold	7,500	–	–	﹤0.01%	80
2022 Q2	$10K	Hold	7,500	–	–	﹤0.01%	81
2022 Q1	$16K	Hold	7,500	–	–	﹤0.01%	79
2021 Q4	$28K	Hold	7,500	–	–	﹤0.01%	78
2021 Q3	$37K	Hold	7,500	–	–	﹤0.01%	76
2021 Q2	$51K	Hold	7,500	–	–	﹤0.01%	76
2021 Q1	$52K	Hold	7,500	–	–	﹤0.01%	77
2020 Q4	$75K	Hold	7,500	–	–	0.01%	75
2020 Q3	$27K	Hold	7,500	–	–	﹤0.01%	74
2020 Q2	$37K	Hold	7,500	–	–	﹤0.01%	73
2020 Q1	$24K	Hold	7,500	–	–	﹤0.01%	70
2019 Q4	$43K	Hold	7,500	–	–	﹤0.01%	71
2019 Q3	$47K	Hold	7,500	–	–	﹤0.01%	79
2019 Q2	$57K	Hold	7,500	–	–	﹤0.01%	78
2019 Q1	$39K	Hold	7,500	–	–	﹤0.01%	84
2018 Q4	$49K	Hold	7,500	–	–	﹤0.01%	83
2018 Q3	$128K	Hold	7,500	–	–	0.01%	78
2018 Q2	$100K	Hold	7,500	–	–	0.01%	77
2018 Q1	$119K	Hold	7,500	–	–	0.01%	76
2017 Q4	$86K	Sell	7,500 -5,000	-40%	-$74.5K	0.01%	76
2017 Q3	$238K	Hold	12,500	–	–	0.02%	67
2017 Q2	$302K	Hold	12,500	–	–	0.03%	64
2017 Q1	$247K	Buy	12,500 +2,410	+24%	+$53.8K	0.02%	69
2016 Q4	$243K	Hold	10,090	–	–	0.02%	72
2016 Q3	$280K	Hold	10,090	–	–	0.03%	70
2016 Q2	$246K	Buy	+10,090	New	+$286K	0.03%	69

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Cacti Asset Management's PGEN Position: Q2 2025 in Review

Cacti Asset Management sold out of Precigen (PGEN) in Q2 2025, closing a stake of 7,500 shares — an estimated $11.9K sold.

Cacti Asset Management first reported a position in PGEN in Q2 2016 and held it in 36 quarters. The position peaked at $302K in Q2 2017. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

Cacti Asset Management reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
Cacti Asset Management sold 7,500 Precigen shares in Q2 2025, an estimated $11.9K.
Cacti Asset Management first reported a position in Precigen in Q2 2016 and held it in 36 quarters.
Cacti Asset Management's Precigen position peaked at $302K in Q2 2017.
147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Cacti Asset Management's 13F filing for Q2 2025, filed 1 Jul 2025.